HXN-1013

N/A

Report date: 2026/03/19 15:53:16

Base Information

Drug NameHXN-1013
Drug Alias NameHXN-1013
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Thymic stromal lymphopoietinAnti-Interleukin-33
TargetsThymic stromal lymphopoietinInterleukin-33
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesHelixon Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEarendil Labs
Inactive CompaniesHelixon Ltd
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A